Abstract NG04: Diversity of circulating tumor cells in a mouse pancreatic cancer model identified by single cell RNA sequencing
David T. Ting(Massachusetts General Hospital), Daniel A. Haber(Howard Hughes Medical Institute), Haley Ellis(Broad Institute), Ravi Kapur(Harvard University), Jordan C. Ciciliano(Georgia Institute of Technology), Miguel N. Rivera(University of North Texas), Brian W. Brannigan(Harvard University), Ben S. Wittner(Broad Institute), Shyamala Maheswaran(Massachusetts General Hospital), Olivia Mackenzie(Harvard University), Julie Trautwein(Harvard University), Mehmet Toner(Center for Cancer Research), Ajay M. Shah(University of Wales), Kristina Xega(Takeda (United States)), Mohammad Shahid(Prince Sattam Bin Abdulaziz University), Na Qu(Yangzhou University), Nabeel Bardeesy(Broad Institute), Toshi Shioda(Center for Cancer Research), Sridhar Ramaswamy(Harvard University), David T. Miyamoto(Broad Institute)
Cited by 3
Related Papers
Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1
|Nature|2009|4.2k
Twist, a Master Regulator of Morphogenesis, Plays an Essential Role in Tumor Metastasis
|Cell|2004|3.8k
Isolation of rare circulating tumour cells in cancer patients by microchip technology
|Nature|2007|3.5k
Hormones and Endocrine-Disrupting Chemicals: Low-Dose Effects and Nonmonotonic Dose Responses
|Endocrine Reviews|2012|3.1k